The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

20 May 2022 07:00

RNS Number : 1761M
Circassia Group Plc
20 May 2022
 

Circassia Group plc

("Circassia" or the "Company")

Grant of options

Oxford, UK - 20 May 2022: Circassia Group plc (LSE: CIR) announces that it has granted nominal value options to the Executive Directors over a total of 3,698,277 new ordinary shares in the Company ("Ordinary Shares") under the 2022 Performance Share Plan (the "Options").

The Options will vest on the third anniversary of the date of grant (the "Vesting Date") and are exercisable until the tenth anniversary of the date of grant, subject also to the closing mid-market price of an Ordinary Share either: (a) reaching or exceeding a specified price over a period of 30 consecutive dealing days prior to the Vesting Date or (b) a liquidity event occurring above the specified price (in each case, the "Vesting Level").

33 per cent. of the Options will vest in the event that a Vesting Level of 50p is attained, 66 per cent. of the Options will vest in the event that a Vesting Level of 60p is attained, with 100 per cent. vesting in the event that a Vesting Level of 70p is attained.

The Option awards to each Executive Director are shown below and additional disclosure in relation to PDMR dealing is included at the end of this announcement.

 

Name

Number of shares subject to award

Ian Johnson

1,331,897

Jonathan Emms

1,331,897

Michael Roller

1,034,483

 

Contacts

Circassia

Ian Johnson, Executive Chairman

Michael Roller, Chief Financial Officer

 

+44 (0) 1865 405560

 

 

 

Singer Capital Markets (Nominated Adviser & Broker)

Aubrey Powell / Jen Boorer

 

+44 (0) 20 7496 3000

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Ian Johnson

2. Jonathan Emms

3. Michael Roller

2.

Reason for the notification

a.

Position/status

1. Executive Chairman

2. Chief Operating Officer

3. Chief Financial Officer

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Circassia Group plc

b.

LEI

2138006YAT138TOGA556

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Options over Ordinary Shares of 0.08p each.

 

 

GB00BJVD3B28 ISIN for the Ordinary shares

b.

Nature of the transaction

Grant of share options under the 2022 Performance Share Plan over Ordinary Shares in Circassia

 

c.

Price(s) and volume(s)

Price(s)

 

Volume(s)

1. 0.08p

2. 0.08p

3. 0.08p

1. 1,331,897

2. 1,331,897

3. 1,034,483

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

19 May 2022

f.

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLGDUISBDGDC
Date   Source Headline
31st Jan 20184:03 pmRNSTotal Voting Rights
17th Jan 20182:42 pmRNSBlock Listing Six Monthly Return
17th Jan 20182:37 pmRNSNotification of Major Holdings
8th Jan 20187:00 amRNSTR-1: Notification of major holdings
5th Jan 20185:31 pmRNSHolding(s) in Company
29th Dec 20177:00 amRNSTotal Voting Rights
19th Dec 20175:48 pmRNSNotification of Major Holdings
4th Dec 20177:00 amRNSTudorza® Meets Primary Endpoints in ASCENT Study
30th Nov 20172:53 pmRNSTotal Voting Rights
29th Nov 20177:00 amRNSCircassia Welcomes New NICEAsthma Guidelines
31st Oct 20175:18 pmRNSTotal Voting Rights Update
16th Oct 201711:39 amRNSNotification of Major Holdings
29th Sep 201712:13 pmRNSTotal Voting Rights Update
27th Sep 20177:00 amRNSInterim results six months ended 30 June 2017
18th Sep 20172:52 pmRNSNotification of Major Holdings
18th Sep 20172:19 pmRNSNotification of Major Holdings
12th Sep 20177:00 amRNSEuropean Launch of NIOX VERO® Nasal Mode
7th Sep 20177:00 amRNSPrimary Endpoints Met in AMPLIFY Phase III Study
1st Sep 20175:21 pmRNSNotification of Major Holdings
31st Aug 201712:52 pmRNSTotal Voting Rights
24th Aug 20174:06 pmRNSNotice of Interim Results
31st Jul 20177:00 amRNSTotal Voting Rights Update
21st Jul 20178:52 amRNSNotification of Major Holdings
17th Jul 20176:28 pmRNSDirector/PDMR Shareholding
14th Jul 201712:29 pmRNSNotification of Major Holdings
30th Jun 20177:00 amRNSBlock Listing Six Monthly Return
30th Jun 20177:00 amRNSTotal Voting Rights Update
29th Jun 20176:08 pmRNSNotification of Major Interest in Shares
27th Jun 201711:48 amRNSNotification of Major Interest in Shares
26th Jun 20174:27 pmRNSNotification of Major Interest in Shares
15th Jun 20175:40 pmRNSNotification of Major Interest in Shares
5th Jun 20175:36 pmRNSDirector/PDMR Shareholding
31st May 201710:59 amRNSTotal Voting Rights Update
31st May 20177:00 amRNSBlock Listing Application
26th May 201711:35 amRNSResult of AGM 2017
26th May 20177:00 amRNSHolding(s) in Company
28th Apr 20175:20 pmRNSAnnual Report and Notice of Annual General Meeting
28th Apr 20173:15 pmRNSTotal Voting Rights Update
25th Apr 20177:02 amRNSNon-Executive Director Retirements
25th Apr 20177:00 amRNSPreliminary Results for Year Ended 31 Dec 2016
18th Apr 20176:09 pmRNSHolding(s) in Company
18th Apr 20174:51 pmRNSNotification of Major Interest in Shares
18th Apr 201710:20 amRNSNotification of Major Interest in Shares
18th Apr 20177:00 amRNSTop-Line Results of House Dust Mite Allergy Study
13th Apr 20176:02 pmRNSHolding(s) in Company
13th Apr 20175:57 pmRNSHolding(s) in Company
12th Apr 20175:34 pmRNSNotification of Major Interest in Shares
12th Apr 20179:00 amRNSNotice of Results
12th Apr 20178:30 amRNSCompletion of Transaction and Admission to Trading
11th Apr 20179:00 amRNSEarly Termination of HSR Waiting Period Granted

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.